BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31191607)

  • 21. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma.
    Shi T; Hua Q; Ma Z; Lv Q
    Pathol Res Pract; 2017 Dec; 213(12):1464-1469. PubMed ID: 29103765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of miR-628-3p and miR-641 is involved in rifampin-mediated CYP3A4 induction in HepaRG cells.
    Yan L; Liu J; Zhao Y; Nie Y; Ma X; Kan Q; Zhang L
    Pharmacogenomics; 2017 Jan; 18(1):57-64. PubMed ID: 27967330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-20a-5p Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting the Expression of CD36.
    Wang X; Ma Y; Yang LY; Zhao D
    Front Cell Dev Biol; 2020; 8():596329. PubMed ID: 33344451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A GDF15 3' UTR variant, rs1054564, results in allele-specific translational repression of GDF15 by hsa-miR-1233-3p.
    Teng MS; Hsu LA; Juan SH; Lin WC; Lee MC; Su CW; Wu S; Ko YL
    PLoS One; 2017; 12(8):e0183187. PubMed ID: 28806401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-Transcriptional Effects of miRNAs on PCSK7 Expression and Function: miR-125a-5p, miR-143-3p, and miR-409-3p as Negative Regulators.
    Malakootian M; Naeli P; Mowla SJ; Seidah NG
    Metabolites; 2022 Jun; 12(7):. PubMed ID: 35888711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA regulation of transthyretin in trophoblast biofunction and preeclampsia.
    Cao G; Cui R; Liu C; Zhang Z
    Arch Biochem Biophys; 2019 Nov; 676():108129. PubMed ID: 31593646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
    Yang H; Zheng W; Zhao W; Guan C; An J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic evaluation of microRNAs in regulating human hepatic CYP2E1.
    Wang Y; Yu D; Tolleson WH; Yu LR; Green B; Zeng L; Chen Y; Chen S; Ren Z; Guo L; Tong W; Guan H; Ning B
    Biochem Pharmacol; 2017 Aug; 138():174-184. PubMed ID: 28438567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.
    Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY
    Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway.
    Zhang P; Xu L; Guan H; Liu L; Liu J; Huang Z; Cao X; Liao Z; Xiao H; Li Y
    Metabolism; 2017 Aug; 73():9-21. PubMed ID: 28732575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis.
    Vulf M; Shunkina D; Komar A; Bograya M; Zatolokin P; Kirienkova E; Gazatova N; Kozlov I; Litvinova L
    Front Cell Dev Biol; 2021; 9():736677. PubMed ID: 34568346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-200a-3p improves neonatal necrotizing enterocolitis by regulating RIPK1.
    Liu Y; Wang Z; Huang H; Shou K
    Am J Transl Res; 2021; 13(11):12662-12672. PubMed ID: 34956481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
    Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
    Front Oncol; 2020; 10():756. PubMed ID: 32509578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-200a-3p Is a Positive Regulator in Cardiac Hypertrophy Through Directly Targeting WDR1 as Well as Modulating PTEN/PI3K/AKT/CREB/WDR1 Signaling.
    Yang X; Chen G; Chen Z
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):453-461. PubMed ID: 31651553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p.
    Chen Y; Zeng L; Wang Y; Tolleson WH; Knox B; Chen S; Ren Z; Guo L; Mei N; Qian F; Huang K; Liu D; Tong W; Yu D; Ning B
    Biochem Pharmacol; 2017 Dec; 145():178-191. PubMed ID: 28822783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes.
    Li C; Ni J; Liu YX; Wang H; Liang ZQ; Wang X
    PLoS One; 2017; 12(1):e0168049. PubMed ID: 28045918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
    Chen X; Tan XR; Li SJ; Zhang XX
    Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease.
    López-Riera M; Conde I; Tolosa L; Zaragoza Á; Castell JV; Gómez-Lechón MJ; Jover R
    Front Pharmacol; 2017; 8():3. PubMed ID: 28179883
    [No Abstract]   [Full Text] [Related]  

  • 39. The Long Non-coding RNA MEG3/miR-let-7c-5p Axis Regulates Ethanol-Induced Hepatic Steatosis and Apoptosis by Targeting NLRC5.
    Wang Q; Li M; Shen Z; Bu F; Yu H; Pan X; Yang Y; Meng X; Huang C; Li J
    Front Pharmacol; 2018; 9():302. PubMed ID: 29692724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.